The Journal of Urology
Volume 178, Issue 3, Supplement , Pages S30-S35, September 2007

Castration Resistant, Taxane Naïve Metastatic Prostate Cancer: Current Clinical Approaches and Future Directions

  • Gretchen A. Gignac

      Affiliations

    • Genitourinary Oncology Service, Department of Medicine, and Sidney Kimmel Center for Prostate and Urologic Cancers, Memorial Sloan-Kettering Cancer Center, New York, New York
    • Department of Medicine, Joan and Sanford E. Weill College of Medicine of Cornell University, New York, New York
  • ,
  • Michael J. Morris

      Affiliations

    • Genitourinary Oncology Service, Department of Medicine, and Sidney Kimmel Center for Prostate and Urologic Cancers, Memorial Sloan-Kettering Cancer Center, New York, New York
    • Department of Medicine, Joan and Sanford E. Weill College of Medicine of Cornell University, New York, New York
    • Corresponding Author InformationCorrespondence: Genitourinary Oncology Service, Memorial Sloan-Kettering Cancer Center, 1275 York Ave., Box 444, New York, New York 10021 (telephone: 646-422-4469; FAX: 212-988-0701).
    • Financial interest and/or other relationship with Sanofi Aventis, Cytogen and Agensys.
  • ,
  • Maha Hussain

      Affiliations

    • Departments of Medicine and Urology, University of Michigan Comprehensive Cancer Center, Ann Arbor, Michigan
    • Financial interest and/or other relationship with Merck.

published online 18 July 2007.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 30.00 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 Supported by National Institutes of Health Grants 5-T32-CA09207 and 5K23CA102544.

PII: S0022-5347(07)01092-0

doi:10.1016/j.juro.2007.04.033

The Journal of Urology
Volume 178, Issue 3, Supplement , Pages S30-S35, September 2007